Antibody Treatment Failed In Preventing COVID-19 In Exposed Patients – Astrazeneca
Anglo-Swedish drug maker AstraZeneca said on Tuesday a study of its monoclonal antibody treatment, AZD7442, did not meet the main goal of preventing symptomatic Coronavirus in people…
Read More...
Read More...